BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 15968423)

  • 1. [Serum response factor participates in RhoA-induced endothelial cell F-actin rearrangements].
    Han YL; Yu HB; Yan CH; Meng ZM; Zhang XL; Kang J; Li SH; Wang SW
    Sheng Li Xue Bao; 2005 Jun; 57(3):295-302. PubMed ID: 15968423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tumor necrosis factor-α promote permeability of human umbilical vein endothelial cells via activating RhoA-ERK1/2 pathway].
    Yan CH; Yu HB; Huang MF; Li J; Zhang XL; Han YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jun; 39(6):531-7. PubMed ID: 21924080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actin cytoskeleton dynamics promotes leptin-induced vascular smooth muscle hypertrophy via RhoA/ROCK- and phosphatidylinositol 3-kinase/protein kinase B-dependent pathways.
    Zeidan A; Paylor B; Steinhoff KJ; Javadov S; Rajapurohitam V; Chakrabarti S; Karmazyn M
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1110-6. PubMed ID: 17562852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LIM kinase and Diaphanous cooperate to regulate serum response factor and actin dynamics.
    Geneste O; Copeland JW; Treisman R
    J Cell Biol; 2002 May; 157(5):831-8. PubMed ID: 12034774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential involvement of the integrin-linked kinase (ILK) in RhoA-dependent rearrangement of F-actin fibers and induction of connective tissue growth factor (CTGF).
    Graness A; Giehl K; Goppelt-Struebe M
    Cell Signal; 2006 Apr; 18(4):433-40. PubMed ID: 15970428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF-2 induced reorganization and disruption of actin cytoskeleton through PI 3-kinase, Rho, and Cdc42 in corneal endothelial cells.
    Lee HT; Kay EP
    Mol Vis; 2003 Dec; 9():624-34. PubMed ID: 14685150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RhoA/Rho kinase pathway regulates nuclear localization of serum response factor.
    Liu HW; Halayko AJ; Fernandes DJ; Harmon GS; McCauley JA; Kocieniewski P; McConville J; Fu Y; Forsythe SM; Kogut P; Bellam S; Dowell M; Churchill J; Lesso H; Kassiri K; Mitchell RW; Hershenson MB; Camoretti-Mercado B; Solway J
    Am J Respir Cell Mol Biol; 2003 Jul; 29(1):39-47. PubMed ID: 12600823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation.
    Sahai E; Alberts AS; Treisman R
    EMBO J; 1998 Mar; 17(5):1350-61. PubMed ID: 9482732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGFbeta1-induced aortic endothelial morphogenesis requires signaling by small GTPases Rac1 and RhoA.
    Varon C; Basoni C; Reuzeau E; Moreau V; Kramer IJ; Génot E
    Exp Cell Res; 2006 Nov; 312(18):3604-19. PubMed ID: 16978608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diaphanous-related formin mDia1 controls serum response factor activity through its effects on actin polymerization.
    Copeland JW; Treisman R
    Mol Biol Cell; 2002 Nov; 13(11):4088-99. PubMed ID: 12429848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of Rho kinase in reorganization of the vascular endothelial cytoskeleton induced by rat burn serum].
    Zheng HZ; Zhao KS; Huang QB
    Zhonghua Shao Shang Za Zhi; 2005 Jun; 21(3):181-4. PubMed ID: 15996278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct involvement of cdc42 and RhoA GTPases in actin organization and cell shape in untransformed and Dbl oncogene transformed NIH3T3 cells.
    Olivo C; Vanni C; Mancini P; Silengo L; Torrisi MR; Tarone G; Defilippi P; Eva A
    Oncogene; 2000 Mar; 19(11):1428-36. PubMed ID: 10723134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho and ROCK signaling in VEGF-induced microvascular endothelial hyperpermeability.
    Sun H; Breslin JW; Zhu J; Yuan SY; Wu MH
    Microcirculation; 2006; 13(3):237-47. PubMed ID: 16627366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta1 integrin and organized actin filaments facilitate cardiomyocyte-specific RhoA-dependent activation of the skeletal alpha-actin promoter.
    Wei L; Wang L; Carson JA; Agan JE; Imanaka-Yoshida K; Schwartz RJ
    FASEB J; 2001 Mar; 15(3):785-96. PubMed ID: 11259397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidized LDL induces proliferation and hypertrophy in human umbilical vein endothelial cells via regulation of p27Kip1 expression: role of RhoA.
    Seibold S; Schürle D; Heinloth A; Wolf G; Wagner M; Galle J
    J Am Soc Nephrol; 2004 Dec; 15(12):3026-34. PubMed ID: 15579505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum response factor is crucial for actin cytoskeletal organization and focal adhesion assembly in embryonic stem cells.
    Schratt G; Philippar U; Berger J; Schwarz H; Heidenreich O; Nordheim A
    J Cell Biol; 2002 Feb; 156(4):737-50. PubMed ID: 11839767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RhoA activation promotes transendothelial migration of monocytes via ROCK.
    Honing H; van den Berg TK; van der Pol SM; Dijkstra CD; van der Kammen RA; Collard JG; de Vries HE
    J Leukoc Biol; 2004 Mar; 75(3):523-8. PubMed ID: 14634067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p38 MAP kinase mediates burn serum-induced endothelial barrier dysfunction: involvement of F-actin rearrangement and L-caldesmon phosphorylation.
    Chu ZG; Zhang JP; Song HP; Hu JY; Zhang Q; Xiang F; Huang YS
    Shock; 2010 Sep; 34(3):222-8. PubMed ID: 20160665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of RhoA on human umbilical vein endothelial cell migration and angiogenesis in vitro.
    Zhao L; Xu G; Zhou J; Xing H; Wang S; Wu M; Lu YP; Ma D
    Oncol Rep; 2006 May; 15(5):1147-52. PubMed ID: 16596177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of the myofibroblastic phenotype in human gingival fibroblasts by transforming growth factor-beta1: role of RhoA-ROCK and c-Jun N-terminal kinase signaling pathways.
    Smith PC; Cáceres M; Martinez J
    J Periodontal Res; 2006 Oct; 41(5):418-25. PubMed ID: 16953819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.